The neutrophil-to-lymphocyte ratio: a narrative review.

Related Articles

The neutrophil-to-lymphocyte ratio: a narrative review.

Ecancermedicalscience. 2016;10:702

Authors: Faria SS, Fernandes PC, Silva MJ, Lima VC, Fontes W, Freitas-Junior R, Eterovic AK, Forget P

Abstract
Cellular-mediated inflammatory response, lymphocytes, neutrophils, and monocytes are increasingly being recognised as having an important role in tumorigenesis and carcinogenesis. In this context, studies have suggested that the neutrophil-to-lymphocyte ratio (NLR) can be used as an independent prognostic factor in a variety of cancers. Particularly in breast cancer, several studies have shown that a high NLR is associated with shorter survival. Because the NLR can be easily determined from the full blood count, it could potentially provide a simple and inexpensive test cancer prognosis. This review addresses the possibilities and limitations of using the NLR as a clinical tool for risk stratification helpful for individual treatment of breast cancer patients. The potential underlying phenomena and some perspectives are discussed.

PMID: 28105073 [PubMed - in process]

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jLpSlg
via IFTTT